Galmed Pharmaceuticals Ltd (GLMD)
Q3 2018 Earnings Conference Call
November 5, 2018 08:30 AM ET
Executives
Paul Arndt - Managing Director, LifeSci Advisors
Allen Baharaff - Co-Founder, Chief Executive Officer
Yohai Stenzler - Chief Financial Officer
Liat Hayardeny - Chief Scientific Officer
Tali Gorfine - Chief Medical Officer
Analysts
Adam Walsh - Stifel Nicolaus
Steve Seedhouse - Raymond James
Jason McCarthy - Maxim Group
Presentation
Operator
Good morning and welcome to the Galmed Pharmaceuticals’ Third Quarter 2018 Earnings Call. This conference is being recorded.
I would now like to turn the call over to Paul